FDA Approves First New Drug With International Group
The approval is for the oral therapy tucatinib (Tukysa, Seattle Genetics) for the treatment of advanced HER2-positive breast cancer. FDA Approvals …read more
‘Encouraging’ Results With Pre-Op Therapy for DCIS
There’s a template now for treating DCIS with pre-operative endocrine therapy, and it shows that 15% of patients have a pathologic complete response. Medscape Medical News …read more
How to Sanitize N95 Masks for Reuse: NIH Study
Vaporized hydrogen peroxide was the most beneficial of four methods tested. The study, which has not been peer reviewed, also found that ultraviolet light and heat treatments can extend mask life. Medscape Medical News …read more